Podcasts about Digital health

In 1987, Mary P. Lovato, a member of Kewa Pueblo in New Mexico, was diagnosed with acute leukemia. To receive a bone marrow transplant, she had to travel more than 800 miles from home because specialized cancer care was unavailable through the Indian Health Service. When she returned, she discovered another obstacle: many in her community feared cancer so deeply that they avoided speaking about it altogether.This episode examines how cancer survivorship exposed profound inequities in the American healthcare system. Long before health equity became a national priority, advocates from underserved communities were confronting disparities rooted in geography, poverty, racism, language, underfunded healthcare systems, and historical mistrust of medical institutions. Their work demonstrated that scientific advances alone cannot improve survival if patients cannot reach, afford, or trust the care available to them.The story follows pioneers including Mary P. Lovato, who built the first national Native-led cancer support and education program for Indigenous communities, and Maimah Karmo, founder of the Tigerlily Foundation, whose breast cancer diagnosis inspired a movement to improve early detection, clinical trial participation, and representation for Black women. Their advocacy challenged longstanding barriers to culturally competent care while highlighting persistent inequities in access to screening, fertility preservation, navigation, and innovative treatments.The episode also explores why diversity in clinical research matters. For decades, many cancer clinical trials disproportionately enrolled White patients, limiting both access to promising therapies and the scientific understanding of how treatments perform across different populations. Researchers, patient advocates, and community leaders responded by redesigning outreach, improving patient navigation, reducing logistical barriers, and insisting that affected communities help shape the research itself.Cancer survivorship cannot be measured solely by scientific breakthroughs. It also depends on whether every patient has a meaningful opportunity to benefit from them. The pursuit of health equity remains one of the defining challenges and enduring responsibilities of modern oncology.RELATED LINKSNational Cancer Institute | Cancer Health Disparities⁠Indian Health Service⁠Tigerlily Foundation⁠National Cancer Institute | Cancer Clinical Trials⁠American Indian Cancer Foundation⁠Abramson Cancer Center | University of Pennsylvania⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

It's our monthly Digital Health Download, and September's stories all circle the same tension: technology keeps promising to fix healthcare's problems, but just as often it moves them somewhere else, or creates new ones entirely. This week, Halle unpacks a news-heavy month, weighing who actually benefits as markets, algorithms, and AI get closer to our health decisions.We cover:Americans can now bet on clinical trials and FDA regulatory reviews - but do we want that?Meta's massive settlement over harming childrenThe surprising reason AI might be making healthcare more expensive instead of lessA new study on the biggest lever we're not pulling to bend the healthcare cost curveTwo lawsuits rattling a popular wearable and a celebrity-backed mental health startupWhat a widely used drug class reveals about bias in hiring, and the uncomfortable questions that raises⸺

In 2000, Katie Couric underwent a live colonoscopy on national television following the death of her husband, Jay Monahan, from colorectal cancer at age 42. The broadcast demystified a procedure many Americans feared, led to an estimated 20% increase in colonoscopy screenings, and became one of the clearest examples of how public storytelling can change healthcare behavior.This episode examines how celebrities, journalists, filmmakers, and entertainers helped reshape the public conversation about cancer during a period when survivorship was becoming increasingly visible. As breakthroughs in targeted therapies, immunotherapy, and early detection allowed more people to live beyond cancer, public figures used their platforms to encourage screening, reduce stigma, and accelerate research. Their influence extended far beyond awareness campaigns, helping transform cancer from a private diagnosis into a national public health conversation.Central to this story is Laura Ziskin, the Hollywood producer behind Pretty Woman and the Spider-Man films, whose metastatic breast cancer diagnosis inspired the creation of Stand Up To Cancer. Working alongside Couric and leaders from entertainment, journalism, and biomedical research, Ziskin championed a new funding model that required multidisciplinary scientific collaboration, helping accelerate discoveries that contributed to multiple FDA-approved cancer therapies. The episode also highlights the advocacy of actor Patrick Dempsey, whose family's experience with ovarian cancer led to the creation of the Dempsey Center, expanding support for patients and caregivers beyond medical treatment.The story also asks what celebrity advocacy often leaves unsaid. Financial toxicity, caregiver burden, chronic pain, mental health, and the long-term effects of treatment rarely receive the same attention as dramatic diagnoses or breakthrough cures. As cancer survivorship continues to evolve, the greatest challenge may not be convincing people to care about cancer, but helping them understand what it truly means to live with and beyond it.RELATED LINKSStand Up To Cancer⁠Katie Couric Media⁠Dempsey Center⁠American Association for Cancer Research⁠National Cancer Institute⁠Dana-Farber Cancer Institute | Adult Survivorship Program⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

"I'd already finished my cardiovascular unit. I'd finished my pulmonary unit. I had never heard about this in any of my classes." That was Dr. Joel Bervell's reaction to discovering that a device used every day in hospitals -- the pulse oximeter -- reads less accurately on darker skin tones. He posted a 30-second video about this consequential discrepancy that, to his utter surprise, gained over 500,000 views by the next morning. That video launched Dr. Bervell into orbit as a social media presence and created his identity as The Medical Mythbuster. In just a few years, he's built a following of two million people, earned a Peabody Award and was named to the inaugural Time 100 Creators list, all while finishing his residency.  On this episode of Raise the Line, host Lindsey Smith welcomes Dr. Bervell to explore the roots of this kind of bias and the real world impact of drawing attention to it. “The most impactful biases in medicine exist because no one stops to ask who was included in the original data and who was left out,” Dr. Bervell explains. Stay tuned to also learn about: His YouTube animated series The Doctor is In which helps kids understand how their bodies work, as well as providing medical role models; How to build trust with marginalized communities; His forthcoming book, The Default Body which examines who medicine was actually designed for. Mentioned in this episode:Dr. Bervell on InstagramTikTok ChannelFacebook"The Doctor Is In" Show If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

In 2006, a landmark report titled Closing the Gap: Research and Care Imperatives for Adolescents and Young Adults with Cancer confirmed what young survivors had been saying for years. While survival rates for children and older adults had steadily improved, adolescents and young adults had experienced decades of stalled progress. They had become cancer's lost generation.This episode explores how young adult survivors transformed their shared isolation into one of the most influential grassroots movements in cancer advocacy. Diagnosed during the years typically devoted to education, careers, relationships, and starting families, patients between the ages of 15 and 39 confronted challenges that extended far beyond treatment. Fertility preservation, sexual health, employment, financial toxicity, insurance, and long-term quality of life were rarely discussed in oncology clinics, leaving many to navigate survivorship alone.The episode follows advocates including Tamika Felder, Lindsay Avner, Heidi Adams, Doug Ulman, and Dr. Archie Bleyer, whose research and advocacy fundamentally changed how medicine understands adolescent and young adult cancer. Through organizations including Planet Cancer, Fertile Hope, the Lance Armstrong Foundation, and later Stupid Cancer, survivors built online communities, educational resources, conferences, and national partnerships that challenged long-standing assumptions about cancer care. Their work helped establish fertility preservation as a standard discussion before treatment, expanded research dedicated to adolescent and young adult oncology, and elevated quality of life as a critical clinical outcome alongside survival.The movement also demonstrated the power of lived experience to reshape medicine. Survivors became researchers, educators, nonprofit founders, and policy advocates, insisting that cancer care account not only for years of life saved, but for the lives patients hoped to build afterward.What began as a search for peers evolved into a national movement that permanently transformed adolescent and young adult oncology. Today, dedicated research programs, clinical fellowships, survivorship resources, and patient advocacy organizations continue to build on the foundation these young cancer mavericks created.RELATED LINKSNational Cancer Institute | Adolescent and Young Adult (AYA) Cancer Program⁠Closing the Gap: Research and Care Imperatives for Adolescents and Young Adults with Cancer⁠American Society of Clinical Oncology | Fertility Preservation Guidelines⁠Stupid Cancer⁠Livestrong Foundation⁠Journal of Adolescent and Young Adult Oncology⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Tony Ambrozie, Senior Vice President, Chief Digital & Technology Officer - Pharmacy, CVS Health Enterprise Digital, discusses Health 100, healthcare interoperability and how AI can help connect fragmented patient data, coordinate care and improve the consumer experience. He also shares his perspective on responsible AI, leadership and using technology to keep people at the center of healthcare transformation.

We don't talk enough about how hard it actually is to build a healthcare startup. Behind SmarterDx's story, now one of the biggest health AI exits to date, were 18 months without a single customer, a pivot that seemed to make no product sense, and two co-founders who went back to working as hospitalists just to get by.In this episode, Steve gets the real story from Dr. Michael Gao and Dr. Joshua Geleris about the challenges they faced and what ultimately unlocked real growth and led to their billion+ acquisition by New Mountain Capital.We cover:Why their first product idea failed and what customer objections actually taught them to build insteadThe counterintuitive workflow that made contingency pricing possibleHow AI translation of clinical notes into billing codes now outperforms the average human, and what that means for coders and nursesWhy "moat" is the wrong metaphor and what a flywheel looks like insteadWhat they'd do differently in the acquisition processAbout our guests:Michael Gao, MD, the CEO and co-founder of SmarterDx. Prior to founding SmarterDx, Dr. Gao was the Medical Director for Transformation at NewYork-Presbyterian, where he led applied AI development, implementation, and strategy for the health system. Dr. Gao holds faculty positions at the Icahn School of Medicine at Mount Sinai and Weill Cornell Medicine. Dr. Gao completed his internship and residency in Internal Medicine at NewYork-Presbyterian.. He received his M.D. from the University of Michigan and a B.S from the University of California Los Angeles.Josh Geleris, MD, is the Head of Product and co-founder of SmarterDx. Prior to SmarterDx, he was Assistant Professor of Medicine at Columbia University, where he was funded by the National Institutes of Health and the Department of Defense for clinical informatics and data science, and led implementation of Epic for providers. Dr. Geleris completed his MD at the Technion-Israeli Institute of Technology and his Internal Medicine internship and residency at NewYork-Presbyterian. ⸺

In 2006, the Institute of Medicine published From Cancer Patient to Cancer Survivor: Lost in Transition, concluding that millions of Americans were surviving cancer only to find themselves navigating a healthcare system unprepared for life after treatment. The report challenged oncology to recognize that curing cancer was not the end of care, but the beginning of survivorship.This episode explores how the growing cancer survivorship movement exposed the long-term consequences of cancer treatment that medicine had largely overlooked. As survival rates improved following the National Cancer Act of 1971, millions of survivors faced chronic fatigue, neuropathy, infertility, cognitive impairment, financial hardship, employment discrimination, anxiety, depression, and post-traumatic stress. These were not rare complications. They became defining features of survivorship for many patients.Drawing on the work of oncologist Dr. Patricia Ganz, survivor advocate Ellen Stovall, and researchers, clinicians, and survivors across the country, the episode examines how survivorship research expanded beyond recurrence and mortality to include quality of life, psychosocial care, rehabilitation, and long-term follow-up. Their efforts helped establish survivorship care plans, multidisciplinary survivorship clinics, and a broader understanding that cancer affects every aspect of a person's life long after treatment ends.The episode also confronts persistent inequities in survivorship care. Insurance coverage often ends when treatment stops, supportive services remain inconsistent, financial toxicity continues to drive medical hardship, and racial, geographic, and socioeconomic disparities still influence who receives comprehensive follow-up care. For many survivors, finishing treatment simply marks the beginning of another struggle.Modern oncology increasingly recognizes that surviving cancer is measured by more than years of life. It is also measured by quality of life, dignity, access to care, and the ability to rebuild a future after treatment. That evolution remains one of the most significant legacies of the cancer survivorship movement.RELATED LINKSNational Academy of Medicine | ⁠From Cancer Patient to Cancer Survivor: Lost in Transition⁠National Cancer Institute Office of Cancer Survivorship⁠American Society of Clinical Oncology | Survivorship Compendium⁠CancerCare⁠HopeWell Cancer Support⁠National Coalition for Cancer Survivorship⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Despite gains in recent years, Black, Hispanic, and Asian communities are still under-represented in the U.S. nursing workforce. We're going to explore that gap and how to close it on this episode of Raise the Line from Elsevier with Dr. Ernest Grant, Vice Dean for Diversity, Equity, Inclusion and Belonging at the Duke University School of Nursing. "You get a patient who is more compliant when they see someone who looks like them, who is from their culture and who can advocate on their behalf," he tells host Lindsey Smith.  Dr. Grant bases that and other insights on a rich professional background that includes 50 years in nursing, being a leading advocate for his profession and breaking down barriers himself as a male nurse of color and the first man elected president of the American Nurses Association.  In this thoughtful conversation, Dr. Grant reflects on what it took to earn credibility in leadership roles, how he's navigating the political climate on DEI initiatives, and the causes and solutions to the persistent shortage in nursing faculty, among other pressing issues. Tune in for a uniquely-informed look at what it will take to build a stronger, more representative nursing profession. Mentioned in this episode: Duke University School of Nursing American Nurses Association If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

This week on Pulse: Amplify, Louise and George speak with EMR pioneer Dr NT Cheung.Dr NT Cheung joined the Hong Kong Hospital Authority when clinical computing was virtually non-existent, and went on to help build one of the world's largest integrated, longitudinal electronic patient record systems.NT reflects on Hong Kong's remarkable 30-year digital health journey, why building its technology in-house proved so valuable, and what other health systems can learn from its clinician-led, incremental approach. They explore the extraordinary opportunity created by three decades of consistently collected patient data, cross-border record sharing with mainland China, and technology's role in supporting an ageing society.NT also offers a timely warning for the AI era: healthcare is too complex to be transformed by technology alone. AI may be extraordinarily powerful, but it remains a tool, and the goal must be to make every interaction between patients, clinicians and the health system a little smoother and better.Connect with NT on LinkedInVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

In 1967, breast surgeon Dr. Harold P. Freeman arrived at Harlem Hospital expecting to treat cancer. Instead, he confronted a healthcare system where poverty, racism, lack of insurance, and institutional barriers often determined who lived long enough to receive treatment. Patients frequently arrived with advanced disease, not because medicine lacked answers, but because access to care had failed them.This episode explores how cancer survivorship expanded beyond medical breakthroughs to include healthcare access, health equity, and organized advocacy. Building on the early work of the National Coalition for Cancer Survivorship (NCCS), it examines the recognition that surviving cancer depended not only on research, but also on whether patients could navigate a fragmented healthcare system.Freeman responded by creating one of the nation's first patient navigation programs at Harlem Hospital in 1990. Community-based navigators helped patients overcome practical barriers including insurance, transportation, appointments, communication, and fear. The model dramatically improved timely diagnosis and treatment, increased breast cancer survival in Harlem, and ultimately inspired the Patient Navigator Outreach and Chronic Disease Prevention Act of 2005, establishing navigation as a cornerstone of modern oncology care.The episode also follows cancer survivor Ellen Stovall, whose leadership transformed survivorship into a national policy movement. Through the NCCS, she united advocates across cancer types, fought for insurance protections, expanded access to clinical trials, helped shape the creation of the Office of Cancer Survivorship at the National Cancer Institute, and organized the landmark 1998 National March for Cancer Survivorship in Washington, D.C. Her work reframed survivorship as a public policy issue rather than a personal experience.Together, Freeman and Stovall demonstrated that scientific progress alone could not eliminate disparities in cancer outcomes. Their work established two enduring principles that continue to shape oncology today: patients need someone to help them navigate care, and survivors must have a voice in the policies that govern it. Modern cancer survivorship depends on both.RELATED LINKSNational Coalition for Cancer Survivorship⁠Harold P. Freeman Patient Navigation Institute⁠National Cancer Institute Office of Cancer Survivorship⁠Patient Navigator Outreach and Chronic Disease Prevention Act of 2005⁠American Cancer Society⁠Tuskegee Study Timeline | Centers for Disease Control and Prevention⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

It's back-to-school szn, and while some kids are stressing over earlier wake-ups, this year's incoming medical students have a bigger question to answer: how do you train for a career that could still have you practicing medicine in the 2070s, when the tools of medicine are changing so rapidly?For our back-to-school episode, we sat down with Stanford University School of Medicine Dean Dr. Lloyd Minor to talk about how AI is already reshaping what future doctors learn and how they're taught, as well as what's still not working in American healthcare.We cover:What medical students are actually being taught about AI, and where Stanford still draws the lineWhy Stanford's tumor boards no longer start with humansThe surprising way Dr. Minor thinks AI could level the playing field in healthcare accessWhy the same AI tools helping patients feel more informed are also making them more anxiousThe counterintuitive reason new medical technology gets more expensive before it gets cheaperWhat's still standing in the way of a vision for precision medicine that's been decades in the makingAbout our guest:Lloyd B. Minor, MD, is a scientist, surgeon, and academic leader. He is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine and Vice President for Medical Affairs at Stanford University. Dr. Minor also is a professor of Otolaryngology–Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy, at Stanford University.As dean, Dr. Minor has had an integral role in setting strategy for the clinical enterprise of Stanford Medicine, an academic medical center that includes the Stanford University School of Medicine, Stanford Health Care, and Stanford Medicine Children's Health. With his leadership, Stanford Medicine leads the biomedical revolution in Precision Health. His book, “Discovering Precision Health,” describes this shift to more preventive, personalized health care and highlights how biomedical advances are dramatically improving our ability to treat and cure complex diseases. In 2021, Dr. Minor articulated and began realizing a bold vision to transform the future of life sciences at Stanford University and beyond – a multi-decade journey enabled by Precision Health.In August 2023, Dr. Minor was appointed Vice President for Medical Affairs to lead all matters related to health and medicine at Stanford University.Before Stanford, Dr. Minor was provost and senior vice president for academic affairs of Johns Hopkins University. Prior to this appointment in 2009, Dr. Minor served as the Andelot Professor and director (chair) of the Department of Otolaryngology–Head and Neck Surgery in the Johns Hopkins University School of Medicine and otolaryngologist-in-chief of The Johns Hopkins Hospital.With more than 160 published articles and chapters, Dr. Minor is an expert in balance and inner ear disorders perhaps best known for discovering superior canal dehiscence syndrome, a debilitating disorder characterized by sound- or pressure-induced dizziness. He subsequently developed a surgical procedure that corrects the problem and alleviates symptoms.In 2012, Dr. Minor was elected to the National Academy of Medicine.—

Welcome to a very, very, very special bonus episode of Out of Patients, and one unlike anything published on this feed before. For nearly 20 years, Matthew Zachary has handed these microphones to patients, caregivers, doctors, advocates, troublemakers, and people with something worth saying. This time, he handed them to his daughter. Hannah Greenzweig grew up around this show, and now she has commandeered the studio with 3 of her wonderfully creative high school friends to talk about something they built entirely themselves. There is an enormous amount of Dad Pride baked into this episode, along with the strange and wonderful realization that sometimes your kid grows up, takes your chair, takes your microphone, and produces a better show without you.Hannah Greenzweig, Michael Aidinov, Gwendolyn Baldini, and Astronomy are student artists from the Roundabout Youth Ensemble at James Madison High School in Brooklyn. Working alongside teaching artists from Roundabout Theatre Company, they spent a school year creating an original play from the ground up, writing every scene, developing every character, and producing the performance themselves.Instead of discussing a Broadway production, they dissect one they invented.Their play, Subject Matter, began with a room full of improbable ideas. Murderous bounce houses, pirate family sagas, underwater adventures, courtroom dance battles, and birthday parties at math museums all competed before the group settled on an absurd rivalry between New York's fictional History Museum and Math Museum. From there, they built a fully staged comedy about institutional competition, sabotage, oversized personalities, and the unexpected discovery that history and mathematics need each other more than either side wants to admit.The conversation pulls back the curtain on a creative process most audiences never see. The students explain how scenes evolved through constant rewrites, how characters emerged from improvisation, how costumes came together with last minute ingenuity, and how rehearsals often collapsed into uncontrollable laughter. They recount cutting favorite ideas, solving production problems with limited resources, and trusting each other enough to keep rewriting until the story worked.The episode also captures something harder to script: teenagers speaking honestly about collaboration without adults translating their experience. They celebrate classmates who stepped into unexpected roles, teachers who quietly held the production together, and the strange joy of creating something that exists only because everyone showed up.It is a conversation about theater, friendship, education, creativity, and what happens when 4 young artists get the microphones and the adults get out of the way.RELATED LINKSRoundabout Theatre CompanyRoundabout Youth EnsembleJames Madison High SchoolFEEDBACKLike this bonus episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

A man is struck by a car on the streets of Los Angeles. In the emergency department, a CT scan ordered to look for traumatic injuries reveals something nobody expected: a mass in his colon. Days later, sitting across from Dr. Belinda Waltman, he calls the accident “a blessing in disguise.” Then he changes the subject. He is less worried about cancer than about whether he can afford to miss another day of work. In this season finale of Standard Deviation, host Dr. Oliver Bogler explores what happens when biomedical science collides with the realities of the healthcare safety net. Dr. Waltman, a primary care physician in Los Angeles County, specializes in expedited cancer workups for uninsured and underinsured patients. Every diagnosis arrives carrying another set of questions about housing, transportation, food insecurity, wages, and survival that rarely appear in medical records or scientific literature. For years, Waltman carried those stories without knowing how to bring them into the academic record. As a full-time clinician without a research lab, grant funding, or publication pipeline, she faced barriers familiar to many working scientists and physicians whose most important observations happen outside traditional research settings. With support from the Life Science Editors Foundation's JEDI program, those experiences became The Margins Matter, a narrative medicine essay published in JAMA that argues the social realities surrounding cancer care are not background details. They are part of the disease itself. Bogler traces how editorial mentorship transformed lived clinical experience into published scholarship while asking a larger question about who gets to shape the scientific record. The conversation examines cancer care, Medicaid, health-related social needs, medical publishing, and the structural incentives that determine which stories become evidence and which disappear from view.The result is a conversation about documentation, visibility, and why the margins of medicine often determine who survives long enough to benefit from its advances.RELATED LINKSDr. Belinda Waltman⁠The Margins Matter | JAMA⁠The Margins Matter | PubMed⁠Life Science Editors Foundation⁠FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What does it take to compete on the world's biggest stage and then pivot to one of the most demanding training paths in professional life? Today's guest, Samantha "Sammy" Kolowrat, has done both, and she has some fascinating insights into the commonalities of those two worlds on this episode of Raise the Line. “Something that really drew me to medicine is the team atmosphere that's there as you work towards a common goal, and there's this level of intensity that's very reminiscent of the experiences I had as a professional athlete.” Originally from Prague, Kolowrat represented Czechia at six IIHF Women's World Championships and the 2022 Beijing Olympics, and also captained the Division I women's hockey team at the University of Vermont while earning degrees in biology and pharmacology.  As she starts an anesthesiology residency at Vanderbilt University, she credits her athletic career with shaping how she handles pressure, feedback, and teamwork in medicine. "The more I improve, the more knowledge I acquire, the more skills I hone, the better care my patients get," she tells host Lindsey Smith, describing what drew her to a field that rewards the same relentless fine-tuning as elite sports. This engaging conversation also explores: How crippling performance anxiety as a Division I athlete ended up preparing Kolowrat for the operating room; Why she was drawn to anesthesiology's "well-oiled machine" atmosphere; The mentorship gap she's working to close for the next generation of athlete-physicians. Mentioned in this episode: Vanderbilt University Anesthesiology Residency Program If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

This week on Pulse: Hot Topics, Louise and George explore the rapidly shifting boundaries of science, AI and human health.They unpack the extraordinary research using AI to design entirely new, functioning viruses, and the biosecurity questions that follow. Then, turning the discussion to South Australia's newly announced Royal Commission into AI and whether governance can possibly keep pace with technological change.Then they look at the emerging era of the “continuous human”: Germany's €40 million push to crack continuous hormone monitoring, and Google's enormous SensorFM foundation model, trained on more than a trillion minutes of wearable data, which could point towards a future of personalised, continuous health intelligence.Plus, George recommends Paper Guide for scientific research, and we highlight two international opportunities for clinicians to contribute to research on AI in healthcare.Research Opportunities:Clinicians – be part of the research into clinician use of AI, open globally LinkAI policy vs frontline reality survey (deadline 2 September) LinkResources:SPRIND Continuous Hormone Monitoring Challenge LinkIda Tin Coined Femtech. Now She's Funding Continuous Hormone Monitoring, Forbes LinkSensorFM: Towards a general intelligence and interface for wearable health data, Google Research LinkRecommendations:Paper Guide LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

In this episode of MedAxiom HeartTalk, host Melanie Lawson, MS speaks with Byron Lee, MD, professor of medicine and cardiology at Stanford, about the growing importance of remote cardiac monitoring in patient care. Dr. Lee shares how extended 30-day monitoring helps improves arrhythmia detection and guides long-term treatment. He also discusses how real-time data transmission and streamlined reporting allow care teams to identify and address serious cardiac events more quickly and confidently.

In 1986, 23 survivors, physicians, nurses, attorneys, and community organizers gathered in Albuquerque, New Mexico, for a weekend that would permanently change the language and politics of cancer. Working late into the night, they debated not only strategy, but identity, ultimately declaring that from the moment of diagnosis, every person with cancer is a survivor.This episode traces the social and political forces that gave birth to the modern cancer survivorship movement. As advances in early detection and treatment allowed more people to live beyond cancer, survivors discovered that finishing treatment did not mean returning to normal life. Many faced employment discrimination, loss of insurance, social stigma, infertility, chronic health complications, and a healthcare system that viewed survival as the end of care rather than the beginning of a new chapter.Against the backdrop of the civil rights, disability rights, and community health movements of the 1960s and 1970s, physicians, activists, and survivors challenged medicine's paternalistic culture and demanded a greater voice in decisions affecting their lives. Central to this story are physician and survivor Dr. Fitzhugh Mullan, whose landmark 1985 essay, Seasons of Survival, redefined survivorship as a lifelong continuum, and community organizer Katherine Logan, whose determination united dozens of grassroots organizations into what became the National Coalition for Cancer Survivorship.The coalition's founding established principles that continue to shape oncology today. Survivors were no longer defined solely by disease or treatment outcomes. Their experiences became evidence. Their voices became essential to clinical research, healthcare policy, and patient advocacy. By redefining survivorship as an ongoing experience rather than a destination, the movement challenged medicine to recognize the lasting physical, emotional, financial, and social consequences of cancer.The ideas forged during that weekend in Albuquerque became the foundation of modern cancer survivorship. Nearly 40 years later, the coalition's defining principle, that survivorship begins at diagnosis, continues to influence cancer care, research, policy, and the way millions of people understand life after cancer.RELATED LINKSNational Coalition for Cancer Survivorship⁠National Cancer Institute Office of Cancer Survivorship⁠The New England Journal of Medicine⁠Americans with Disabilities Act (ADA.gov)⁠Library of Congress | Civil Rights History Project⁠White Coat, Clenched Fist by Fitzhugh Mullan⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

We're on summer break and replaying one of our favorite episodes. This episode originally aired on September 22, 2025.A wearable can collect endless data, but it only matters if people trust it enough to change their behavior.In this replay, Oura CEO Tom Hale joins Steve and Michael to explain how the company combines clinical-grade accuracy with a consumer-friendly product. They discuss why the ring's form factor makes overnight tracking so powerful, how Oura turns physiological signals into useful guidance, and why the company is being pulled faster than expected into traditional healthcare.We cover:Why sleep data can reveal changes in the body before symptoms appearHow Oura designed a health product that supports users without judging or nagging themWhy accuracy is the foundation for trust, predictions, and behavior changeHow Oura navigates the boundary between wellness products and regulated medical devicesThe company's expansion into Medicare Advantage, women's health, metabolic health, and clinical care—About our guest:Tom Hale is the Chief Executive Officer at ŌURA and a member of its board. As the CEO he sets the company's business strategy and vision to make health a daily practice for members all over the world. He has over 30 years of experience across the technology and consumer product industry.Before joining ŌURA, Hale was president of Momentive where he drove B2B strategy and led product growth. During his time there he was instrumental in taking the company public in 2018, leading the team in key acquisitions, and driving the evolution and rebranding of the company into a multiple SAAS business. Previously, he held leadership roles at HomeAway and Linden Lab as the Chief Operating Officer and Chief Product Officer, respectively, and held executive roles at Macromedia and Adobe.Hale has a Bachelor of Arts from Harvard University and sits on the boards of Cars.com, RocketReach, and NoiseAware.—If you're enjoying the show, we would so appreciate it if you left us a review!—

Pediatric AI at Scale: How Valley Children's Is Closing the Care Gap in California's Central Valley Host: Janae Sharp Guests: Joe Egan, CIO of Valley Children's Healthcare AI in pediatric healthcare is often talk, not delivery. Joe Egan, CIO of Valley Children's Healthcare, walks through the three layers of AI his team runs today, and how each one turns clinician time back into access for kids. In this conversation: • The three-layer AI model Valley Children's uses: assist, inform, and act, sorted by risk and human oversight • Why ambient documentation earned a clinician wait list, and the metrics that prove it (pajama time, time in notes) • How Epic Cosmos and shared de-identified data help with rare pediatric disease • Why an adult-trained AI model can't be assumed safe for children • The governance and ownership model that makes technology actually stick Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Can your smartphone become part of your mental health treatment? Prescription digital therapeutics (PDTs) promise to do exactly that — but what are they, and do they actually work? In this episode, host Gabe Howard is joined by ADAA member experts John Torous, MD, MBI, a digital psychiatry expert, and Michelle A. Patriquin, PhD, ABPP, a clinical psychologist, to separate hype from reality. Together, they explain what PDTs are — and aren't — and how mental health apps fit into modern treatment. The conversation explores how apps can help bridge long wait times for therapy; reinforce skills learned in treatment; track mood, sleep, and behavior between appointments; and provide valuable insights that improve conversations with mental health clinicians. Listeners will learn: the difference between FDA-approved mental health apps and standard wellness apps why choosing the "best" mental health app is less important than finding one you'll actually use consistently how to avoid common misconceptions about digital mental health tools and make informed choices  If you've ever opened an app store looking for mental health support, this episode will help you separate marketing from evidence so you can make smarter, safer, and more informed decisions about incorporating technology into your mental health care. This episode has been sponsored by the Anxiety and Depression Association of America (ADAA). Our guest, Dr. Michelle Patriquin, is the John S. Dunn Distinguished Professor and Associate Professor in Psychiatry and Behavioral Sciences at McGovern Medical School at UTHealth Houston, and serves as Assistant Dean of Digital Health & Innovation in the UTHealth Houston School of Behavioral Sciences. She is also Co-Director of Research for the John S. Dunn Behavioral Sciences Center, the largest academic inpatient psychiatric hospital in the United States. She is a board-certified clinical psychologist and researcher focused on digital mental health: bringing data-driven, tech-enabled mental health care into real-world clinical setting - especially intensive and inpatient mental healthcare - to improve safety, recovery, and access. Her work is widely published and is supported by state, federal, and foundation funding.  Our guest, John Torous, MD, MBI, is director of the digital psychiatry division in the Department of Psychiatry at Beth Israel Deaconess Medical Center (BIDMC), a Harvard Medical School-affiliated teaching hospital, where he also serves as a staff psychiatrist and associate professor.  He has a background in electrical engineering and computer sciences and received an undergraduate degree in the field from UC Berkeley before attending medical school at UC San Diego. He completed his psychiatry residency, fellowship in clinical informatics, and master's degree in biomedical informatics at Harvard. Dr. Torous is active in investigating the potential of mobile mental health and AI technologies for psychiatry, and his team supports mindapps.org as the largest database of mental health apps, mindApps.ai for benchmarking AI chatbots,  mindLAMP technology platform for scalable digital phenotyping and interventions, and the Digital Navigator program to promote digital equity and access. Dr. Torous has published over 300 peer reviewed articles and 5 book chapters on the topic. He directs the Digital Psychiatry Clinic at BIDMC which seeks to improve access to and quality of mental health care through augmenting treatment with digital innovations. Dr. Torous serves as editor-in-chief for the journal JMIR Mental Health, web editor for JAMA Psychiatry, and a member of various American Psychiatric Association committees.

In 1971, President Richard Nixon signed the National Cancer Act, transforming cancer research with an unprecedented federal investment and launching what became known as the War on Cancer. The legislation did not emerge from scientific discovery alone. It was the culmination of decades of relentless advocacy by researchers, philanthropists, journalists, and patients who believed cancer demanded the same national commitment that had put astronauts on the Moon.This episode traces the origins of the cancer survivorship movement by returning to a time when cancer was rarely discussed in public, many physicians withheld diagnoses from their patients, and surgery offered few lasting cures. It follows the pioneering work of pathologist Dr. Sidney Farber, whose early chemotherapy research challenged conventional thinking, and Mary Lasker, whose political strategy, fundraising, and public campaigns helped transform cancer from a private tragedy into a national public health priority. Together, they built the coalition that reshaped federal support for oncology research and forever changed the relationship between science, government, and the American public.The story then turns to journalist and breast cancer survivor Rose Kushner, whose refusal to accept the standard one-step radical mastectomy challenged nearly a century of surgical dogma. Working alongside surgeon Dr. Bernard Fisher, Kushner helped bring evidence-based medicine to breast cancer treatment through randomized clinical trials that demonstrated less invasive surgery could achieve equivalent outcomes. Their efforts changed clinical practice, strengthened informed consent, and helped establish the principle that patients should participate in decisions about their own care.The breakthroughs explored in this episode extended far beyond new treatments. They redefined the role of patients in medicine, accelerated clinical research, and laid the foundation for modern cancer survivorship. The movement that followed would not simply help more people live longer. It would change what surviving cancer meant.RELATED LINKSNational Cancer Institute⁠National Cancer Act of 1971⁠American Cancer Society⁠Dana-Farber Cancer Institute⁠National Library of Medicine⁠The New England Journal of Medicine⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

An 11-year-old boy in rural Zambia once told Dr. Genesis Mwamba that he was about to attend school wearing shoes for the first time in his life. That moment, Dr. Mwamba says, crystallized why he started the Lead Me Back Foundation to provide school supplies and other support to marginalized communities in his native country.   As you'll learn in this inspiring installment in our NextGen Journeys series, Dr. Mwamba started the foundation in 2021while still a medical student because he had experienced the power of education as an “equalizer” in his own life, taking him from humble roots to a career in medicine. He and his colleagues have grown the bootstrapped organization to a point where it now provides hundreds of thousands of people across the country with educational access, climate education and community health clinics. “I've always been drawn to opportunities and initiatives that bring help to humankind,” he tells Raise the Line host Dr. Parsa Mohri. This episode also explores: What building "with" a community rather than "for" it looks like in practice; The storytelling strategy that attracted donors and partners; How his mother's untimely death inspired his commitment to preventive medicine.   Mentioned in this episode: Lead Me Back Foundation If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

This week on Pulse: Amplify, healthcare's digital future won't be built by technology - it will be built by people.In this episode, Louise and George are joined by Jane Dwelly, Vice President International at CHIME and Chair of the Federation for Informatics Professionals (FedIP), to discuss why professional recognition, leadership and workforce capability are critical to healthcare's future, especially as healthcare enters the AI era.They explore the UK's landmark move to recognise digital health professionals, what other countries can learn, how AI is reshaping workforce skills, and whether the future could include internationally recognised standards for digital health professionals.Connect with Jane on LinkedInResources:FedIP, Federation for Informatics Professionals LinkCHIME CXO Summit, September @Cambridge LinkCHIME membership LinkProfessional Membership for the NHS Digital, Data and Technology Workforce – NHS LinkVisitPulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

Send us Fan MailMedicaid and Medicare used to pay first and chase fraud later. That model is changing fast, and the providers who haven't adapted are about to feel it.In this clip from our episode “AI and The Future Of Behavioral Health”, host John Driscoll and Alon Joffe, Co-Founder and CEO of Eleos Health, break down why the shift to audit-first payment in Medicaid and Medicare is an existential threat for behavioral health organizations already operating on razor-thin margins.Listen to the full episode here

Long before cancer survivors organized into a movement, Hollywood had already shaped how Americans understood the disease. Films rarely used the word “cancer,” physicians often withheld diagnoses from patients, and the people who survived were almost nowhere to be found on screen.Recorded before The Cancer Mavericks: A History of Survivorship became a documentary series, this bonus conversation explores where the project first began. Matthew Zachary sits down with his mother, Roz Greenzweig, a retired educator and lifelong film enthusiast whose memories of classic cinema became an unexpected lens for understanding how cancer was portrayed throughout the twentieth century.Together, they revisit landmark films including Dark Victory, Love Story, and other iconic portrayals that reflected an era when cancer was treated as unspeakable, inevitable, and almost always fatal. Their conversation contrasts those carefully constructed Hollywood narratives with the lived reality of a family confronting a brain cancer diagnosis in 1995, revealing how popular culture both reflected and reinforced the fears surrounding the disease.The discussion also foreshadows many of the themes explored throughout the documentary series: the evolution of patient advocacy, the emergence of cancer survivorship, the role of caregivers, and the power of storytelling to influence public understanding. Before policy changed, before advocacy organizations grew into national movements, conversations like these were already challenging long-held assumptions about what cancer looked like and who had the right to tell its story.Consider this the prologue to The Cancer Mavericks. Before the movement found its history, it began with a family trying to make sense of the stories they had inherited.RELATED LINKSAmerican Cancer Society⁠National Cancer Institute⁠American Film Institute⁠ER (NBC)⁠50/50 (Official)⁠Chasing Life (ABC Family Archive)⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Questions? Email podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of The Agentic Patient, a Faces of Digital Health series on how patients are using AI to find answers the healthcare system didn't give them, Tjasa Zajc talks to Elena Ikonomovska, CEO and Co-Founder of Diadia Health. She stopped trusting chatbots with her own health data — after building an AI company on the problem they create. Elena talks about her two-and-a-half-year journey that followed her mother's death and her own dismissed symptoms — and the causal-reasoning AI she built in response. Guest: Elena Ikonomovska, CEO, Co-Founder & Chief AI Officer, Diadia Health What the conversation covers: - Why Ikonomovska calls generative AI's confident wrong answers "faithful hallucinations" - Building a causal-reasoning engine instead of using large language models for clinical decisions - Why lab "normal" ranges differ by genetics — and what that means for your bloodwork - Her own dismissed thyroid and pre-diabetes symptoms, and what a two-and-a-half-year diagnosis journey actually looks like - The risk of self-diagnosing from ChatGPT-style tools, and what to ask any AI health platform about your data - Why she believes AI should strengthen, not replace, the doctor-patient relationship - Early clinical results: agreement rates with physician judgment and reductions in diagnostic trial-and-error - The equity risk in AI-driven healthcare — who gets access to validated tools, and who doesn't Chapters: 00:00 Intro: why The Agentic Patient series exists 02:30 Meet Elena Ikonomovska and the case for causal AI 03:35 From two decades in machine learning to health AI 07:07 What the model needs: blood panels, genetics, and interactions 09:45 Elena's own diagnosis journey — two and a half years to answers 11:32 Why she wouldn't trust chatbots with her health today 12:40 "Faithful hallucinations": the hidden risk in generative AI 15:04 Inside a causal-reasoning engine built without generative AI 17:32 What happens when clinicians outsource reasoning to chatbots 21:06 Redefining "normal": genetics and personalized lab ranges 27:08 Women's health data gaps and the DTC testing boom 28:13 Strengthening, not replacing, the doctor-patient relationship 31:42 Chatbot safety advice: what patients should never share 38:07 Clinical validation, agreement rates, and what's next Faces of Digital Health: Website: https://www.facesofdigitalhealth.com LinkedIn: https://www.linkedin.com/company/faces-of-digital-health Spotify: https://open.spotify.com/show/4cElKJHrauyP6QJQaCkvdY Apple Podcasts: https://podcasts.apple.com/gb/podcast/faces-of-digital-health/id1194284040 Newsletter: https://fodh.substack.com The Agentic Patient series hub: https://www.facesofdigitalhealth.com/agentic-patient-blog #DigitalHealth #AIinHealthcare #PatientAdvocacy #WomensHealth #HealthTech #ClinicalAI #TheAgenticPatient

This month is about the gap between what a system offers and what people actually get from it: drugs that work better with support nobody's paying for, AI that's already answering more medical questions than most doctors ever will, and a labor market where staying healthy can mean staying stuck. Halle and Michael break down the stories reshaping digital health in August.We cover:Why GLP-1 funding is shifting from prescribing platforms into "companion" ecosystemsThe FDA panel vote that opens a legal pathway for six unapproved peptides, and what this could meanOur thoughts on OpenAI's new ChatGPT Health product, now available to every US adultThe Florida pastor's lawsuit against OpenAIWhy nearly one in four US workers are staying in jobs they'd rather leave, just to keep their health insuranceThe healthcare argument buried inside the bill to make daylight saving time permanentLinks:Rock Health, H1 2026 digital health funding recapHalle's research piece, Virtual GLP-1 startups: Pill mills or the future of obesity care?RAPS, FDA advisory committee backs six peptides for compounding listTechCrunch, OpenAI makes ChatGPT Health available to all US usersCBS News, ChatGPT's medical advice nearly killed a Florida man, lawsuit claimsGallup, One in four US employees locked in jobs for health insuranceThe Hill, House passes Sunshine Protection Act—

The viral robot videos are choreography, not capability. A historian who has lived with a humanoid robot for a year explains what they still can't do. Emily Kate Genatowski is a historian and AI domestic robotics researcher who bought a humanoid robot, lived with it for over a year, and turned the experience into a TED talk. In this episode of Faces of Digital Health, she separates the demo-reel hype of 2026 from what home robots can actually deliver — and what that means for aging populations, caregiver shortages, and healthcare systems hoping robots will help people stay independent at home. She explains why companion robots and chore robots are still entirely separate machines, why her robot cannot get into a car, why retirees are often more enthusiastic about robots than younger workers — and why she believes we are living through a "digital Engels pause," where productivity rises faster than the mechanisms that distribute its benefits. Guest: Emily Kate Genatowski, historian and AI domestic robotics researcher Her TED talk: https://www.youtube.com/watch?v=rIg-Zt7bFHY What the conversation covers: - Humanoid robot hype in 2026 vs real-world capability - Living with a humanoid robot: logistics, frustration, and transport - Robots for elderly care and aging in place - Companion robots vs domestic chore robots — why they're separate devices - The "digital Engels pause": AI productivity without shared gains - US, China, and EU approaches to AI and robotics regulation - Emotional attachment to robots and robot design - Dual-use risks: humanoid robots and drones in warfare - "One soul, many bodies": the future architecture of home robots CHAPTERS CHAPTERS: 00:00 Intro 02:25 Welcome: a historian who lives with a humanoid robot 03:40 2026 robot hype: why the viral videos are choreography 05:45 Why buy a robot? How the year-long experiment began 07:28 From board games to policy: what the project became 08:57 Robots for aging in place — and who's actually optimistic 09:53 Companion robots vs chore robots: two separate machines 13:55 The digital Engels pause: productivity without shared gains 20:09 US, China, Europe: three regulatory cultures for AI and robotics 25:55 Why the robot travels in a box — and can't get into a car 29:58 Robot guilt: emotional attachment without eyes 33:14 Policy, not technology, as the bottleneck for elderly care robots 35:02 Dual use: drones, warfare, and where robotics could go wrong 37:25 One soul, many bodies: the bifurcated future of home robots FOLLOW FACES OF DIGITAL HEALTH Website: https://www.facesofdigitalhealth.com Newsletter: https://fodh.substack.com LinkedIn: https://www.linkedin.com/company/faces-of-digital-health Spotify: https://open.spotify.com/show/4cElKJHrauyP6QJQaCkvdY Apple Podcasts: https://podcasts.apple.com/gb/podcast/faces-of-digital-health/id1194284040 #DigitalHealth #Robotics #HumanoidRobots #AgingInPlace #HealthTech #AI

Send us Fan MailMore than 160 million Americans live in areas with a shortage of mental health providers. The clinicians who do show up are spending hours on documentation, compliance, and eligibility work that has nothing to do with patient care.Alon Joffe, Co-Founder and CEO of Eleos Health, joins host John Driscoll to discuss how AI is reducing administrative burden for behavioral health clinicians and why workflow efficiency is becoming critical for community health centers facing Medicaid funding challenges.

"We have an untapped army of 200,000 PAs that really could step up and drive some change in the healthcare system if we weren't restricted,” says Dr. Jennifer Kolb, capturing her motivation for pushing to update practice regulations for physician associates that date back more than 50 years.  As Chief Medical Officer and Senior Vice President of Clinical Affairs at the American Academy of Physician Associates, Dr. Kolb has been in the middle of the fight at the state and federal level to grant PAs more independence from physicians, full billing rights, and the increased ability to practice across state lines, among other changes.  In this pertinent conversation with Raise the Line host Lindsey Smith, Dr. Kolb explains how these updates could help close huge gaps in access to healthcare, better manage the fight against chronic diseases and improve patient outcomes.   Dr. Kolb also addresses:  Why the name shift from "assistant" to "associate" took her years to fully appreciate; How a 10-year gap in life expectancy across Chicago zip codes shapes her view of health equity; Why PA's shouldn't wait for permission to start making change in their communities. Mentioned in this episode:American Academy of Physician Associates   If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Pediatric Telehealth That Actually Works: 24/7 Access, All 50 States, Real Outcomes Host: Janae Sharp Guests: Lyndsey Garbi, MD, co-founder and CMO of Blueberry Pediatrics Pediatric access is broken, and parents, payers, and health systems are all feeling it. Lyndsey Garbi, MD, co-founder and CMO of Blueberry Pediatrics, joins Megan Antonelli to talk about what 24/7 pediatric telehealth actually looks like at national scale, what the at-home diagnostic kit changes for families, and why the licensing patchwork is quietly costing kids access to care. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

J.D. Whitlock's path to becoming a health system CIO began in the U.S. Air Force, where he served in a variety of healthcare management roles, including a deployment to Afghanistan as Commander of the Patient Administration Division at Bagram Airfield in support of Operation Enduring Freedom in 2007. After retiring from the military, he spent three years at a federal healthcare systems integrator before becoming VP, Enterprise Intelligence at Bon Secours Mercy Health. For the past eight years, he has served as chief information officer at Dayton Children's Hospital.J.D.'s role at Dayton Children's gives him a view into two corners of healthcare that are often underrepresented in digital health conversations: children's health and smaller health systems. Dayton Children's is an independent pediatric system with about $900 million in revenue and 4,900 employees. It runs the same core platforms and must meet many of the same expectations as far larger organizations, but without the same resources. As J.D. puts it, there is no office of transformation; it's everybody's job.In this episode of Healthcare is Hard, J.D. joined Keith Figlioli to discuss the unique technology needs of children's hospitals, and how smaller systems can participate in healthcare's AI transformation. Some of the topics they discussed include:Why pediatric technology requires a different lens. Children's hospitals have unique demands because their patients are not just smaller adults. Digital tools must account for parents and guardians, adolescent privacy, state-specific confidentiality laws, and a patient population whose families increasingly expect digital-first communication. Yet pediatric use cases often remain an afterthought for vendors and investors. He argues that vendors and health tech leaders need to think about pediatrics earlier, because the children's hospitals that serve 25% of the population can't just bolt on adult solutions.Innovating without “science experiment” money. Dayton Children's cannot simply pilot technology because it's interesting. J.D. describes a more disciplined approach in which pilots are treated as phase-one implementations, with the expectation that the organization has already studied the evidence and believes a solution can work. That also means learning from larger pediatric academic medical centers, participating in collaborative networks, and focusing internal resources on ideas that have demonstrated value elsewhere. A platform-first approach to AI. Despite the flood of new AI companies entering healthcare, J.D. believes much of the near-term value will come from the core systems health organizations already use. Point solutions can still earn a place, but they need mature integrations and evidence of ROI. As agents increase AI consumption and introduce more variable costs, health systems will also need to scrutinize whether each new capability is being used enough to justify its expense.Matching ROI to the use case. Not every technology investment has the same kind of return. Some need to show hard savings, while others are about improving the clinician experience, supporting retention, or making care delivery work better. J.D. discusses how the key is being clear about which kind of value you expect.To hear J.D. and Keith discuss these topics and more, listen to this episode of Healthcare is Hard: A Podcast for Insiders.

Artificial intelligence is rapidly becoming part of nearly every conversation in healthcare, but many executives are still asking the same question: What do I actually need to understand to make good business decisions? On this episode of The Dish on Health IT, Brian Dwyer, Business Strategist at Point-of-Care Partners, is joined by Sam Schifman, Principal Engineer for AI at Red Hat and Consultant at Point-of-Care Partners, and Kendra Obrist, Senior Consultant and Payer Interoperability Subject Matter Expert at Point-of-Care Partners, for a practical discussion about how healthcare leaders can evaluate AI opportunities without needing to become technical experts. Together, they explore where AI is delivering measurable value today, why many initiatives struggle to achieve expected outcomes, how to evaluate vendors and risk, what emerging policy and governance trends mean for healthcare organizations, and why strong data quality and interoperability remain essential to AI success. The conversation begins by unpacking what people actually mean when they say they're "using AI." Sam explains the differences between predictive AI, generative AI, conversational AI, and the rapidly emerging world of agentic AI, while Kendra encourages listeners not to get caught up in the terminology. Instead, she emphasizes starting with the business problem that needs to be solved and then determining whether AI is the right tool for the job. Brian then asks where AI is creating meaningful value today. Kendra highlights opportunities across administrative workflows, including documentation, member and provider engagement, claims, prior authorization, and other operational processes where reducing friction can improve efficiency and the user experience. Sam builds on that discussion by encouraging organizations to evaluate AI initiatives based on business outcomes and measurable success metrics rather than technical benchmarks, while recognizing that every AI implementation introduces its own set of risks and tradeoffs. The discussion shifts to why technically impressive AI projects often fail to produce meaningful business results. Kendra explains that organizations can become captivated by polished demonstrations without fully considering governance, data quality, workflow redesign, adoption, and organizational change management. Sam reinforces the importance of understanding AI's inherent uncertainty, establishing appropriate human oversight, and preparing employees for new ways of working as AI becomes integrated into everyday operations. Brian next explores how much AI healthcare executives actually need to understand. Rather than suggesting leaders become AI specialists, Sam encourages executives to develop enough knowledge to ask informed questions and avoid treating AI as an incomprehensible "black box." Kendra complements that advice by encouraging leaders to personally experiment with AI tools so they can better understand both their strengths and limitations before making strategic decisions. As organizations increasingly evaluate AI-enabled products, the panel discusses the questions healthcare leaders should ask prospective vendors. Beyond understanding how an AI solution works, they explore governance, transparency, auditability, accountability, data requirements, quality assurance, and vendor responsibility when AI produces unexpected results. Sam also introduces the concept of AI sovereignty, encouraging organizations to think carefully about long-term dependence on foundational AI models and the flexibility they'll need as technology and regulations continue to evolve. The conversation also examines the rapidly changing policy landscape surrounding AI. Kendra explains how federal agencies are currently taking a sector-specific approach to oversight while states continue introducing their own transparency, bias, and human review requirements. Together, they discuss the operational challenges this evolving patchwork of regulations creates for healthcare organizations operating across multiple states and why adaptability will become increasingly important. Looking ahead, Brian asks what developments deserve executives' attention and which trends may be receiving more attention than they warrant. Sam discusses why organizations should avoid assuming generative AI is always the right answer, highlighting continued opportunities for predictive AI, machine learning, and even traditional software approaches when they better fit the problem. Kendra shares why agentic AI and coordinated teams of AI agents may fundamentally reshape how work is performed across healthcare organizations. The episode concludes with each guest sharing one final takeaway for healthcare leaders. Sam encourages organizations to begin thinking strategically about AI sovereignty, security, and organizational flexibility as AI becomes increasingly embedded in core business operations. Kendra leaves listeners with a broader perspective, comparing AI's impact on knowledge work to the Industrial Revolution's impact on physical labor, and encourages leaders to embrace the technology thoughtfully rather than waiting until they feel they have all the answers. This episode offers practical guidance for healthcare executives who want to make informed AI decisions, ask better questions of vendors and internal teams, and develop an AI strategy grounded in business value rather than technology for technology's sake. Would you be interested in joining a future AI 101 webinar designed for healthcare executives? Sign up to be invited and tell us what you want to learn. We may not be able to pack everything into one webinar but we can do our best to make it as informative as possible. 

Shaju Puthussery and Deepak Ramaswamy are the CEO and CTO of LightSpun, which is rebuilding the back-end engine of insurance processing as agentic AI infrastructure, starting in dental and moving into vision and ancillary benefits. Both came from Overjet, where Deepak was a co-founder and Shaju the first employee, and this conversation is largely about why they walked away from that thesis. Reading X-rays was the visible AI problem. Underneath it was a plumbing problem: claims that never reach clinical review because the documents were wrong, the provider record did not match, or the file never loaded cleanly.Two things in this episode surprised us. The first is that their most valuable asset was an accident. Shaju assumed credentialing was table stakes until a payer CEO told him it was blocking dentist onboarding, and one weekend later Deepak had an approach. That became the rail for roughly 87% of practicing dentists in the US and the provider data spine that feeds adjudication. The second is Shaju's answer to whether anyone profits from claim friction, which is not the cynical answer most people give.We discuss:Why Deepak argues the AI question is not either-or, and why world-class clinical review is worthless if the claim cannot get to itThe moment their business model was confidently wrong: they built for benefits configuration, customers came back asking about credentialing, duplicate records, and file loads, and a startup that planned to do one thing had to bet on tenWhy credentialing was never a Trojan horse for the provider data layer, how the same 200,000-dentist dataset gets monetized twice, and what obligation comes with being the thing the system quietly depends onThe honest ceiling on model performance: 85 to 90% out of the box, and why the climb to 98 or 99% production-ready is where the humans actually liveThe exact decision they will not automate, with the line drawn between deterministic denials (two cleanings a year, a $2,000 annual max) and anything touching a clinical outcomeWhy regulation, not technology, sets the pace, and how they take a faster primary source verification method to their internal NCQA leader with screenshots, timestamps, and source authenticity to prove it still holds upShaju's contrarian read on the $17 to $21 billion admin waste question: no one is winning from the friction, both sides are automating, and the real goal is shifting dollars from admin to careBringing fintech into adjudication with a benefits flex card that carries a Visa or Mastercard rail, blocks non-covered procedures at the chair, and opened doors to a vendor network of roughly 150 health plansThe discipline of not chasing every model release, what Hugging Face taught them early about picking bets, and why the architecture is built to swap foundation models out entirelyDeepak's pushback on the beachhead narrative: dental is several years behind medical, which means the solutions may not transfer cleanly, and they designed for vision and ancillary from day one rather than treating dental as a waypointWhy compliance came before the AI story, with SOC 2 Type 2, HITRUST, and NCQA in place first so they could get in the room with large payers at allThe legacy Deepak actually wants: recognized as the company that automated the boring and the safe, and left the critical decisions with people—Brought to you by: Sage Growth Partners — Value-focused strategy and marketing for growth-driven healthcare organizations.—Where to find Jared:• X: https://x.com/jaredstaylor• LinkedIn: https://www.linkedin.com/in/jaredstaylor/

Rebecca Bloom is a former employee benefits and executive compensation attorney who spent more than 25 years helping women navigate cancer, work, insurance, disability coverage, and financial survival. She is the founder and author of When Women Get Sick, a book built from decades inside the legal, workplace, and patient advocacy systems most people only discover after diagnosis.Bloom started in Big Law at Simpson Thacher handling employee benefits and compensation work she originally chose to pay off student loans. Then her mother was diagnosed with breast cancer. Suddenly the language she used in corporate law offices became the language of survival at home. Explanation of benefits forms. Coverage disputes. Second opinions. Disability protections. Medical leave. Bills no one could explain.That collision changed the direction of her life.In this episode, Bloom explains how serious illness quietly turns patients into unpaid administrators managing paperwork, logistics, financial risk, and emotional labor while trying to survive treatment. She breaks down how employer based health insurance shapes nearly every aspect of cancer care in America and why women often carry the invisible burden of protecting everyone else from discomfort while they themselves fall apart.The conversation digs into workplace power, the illusion of the healthcare “safety net,” caregiver exhaustion, and the class divide hiding underneath patient empowerment culture. Bloom explains why educated, insured women with resources still struggle to navigate healthcare bureaucracy and what happens to patients without those advantages.This episode explores cancer care, health insurance, employee benefits, patient advocacy, workplace protections, caregiving, and the structural incentives that force sick people to become project managers of their own survival.RELATED LINKSRebecca BloomWhen Women Get SickBay Area Cancer ConnectionsSimpson Thacher & BartlettFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Key  topics Evolution of retail technology from typewriters to AI Impact of AI and automation on pharmacy operations The role of pharmacists in patient care and diagnostics The significance of store experience and customer engagement Future trends: longevity, personalized medicine, and digital health Chapters 00:00 Introduction to Steve Perlowski and NACDS 00:31 Historical perspective: retail tech in 1988 01:01 From typewriters to mail correspondence 01:15 Early retail data collection methods 02:34 Impact of internet, cloud, and AI on retail 03:22 Prioritization of pharmacy tech investments 04:12 Transformations in pharmacy customer experience 05:26 Automation and AI in pharmacy operations 07:05 Centralized pharmacy fulfillment and robotics 08:42 Pharmacy's role in healthcare and longevity 09:40 Implications of extended lifespans and biotech advances 12:23 Misunderstandings about pharmacy and healthcare 13:50 The complexity of prescription fulfillment and insurance 17:47 Technological improvements in prescription accuracy 19:02 AI and computer vision in medication dispensing 20:06 GLP1s and the broader store health story 24:37 Emergence of new health categories and merchandising 27:24 Creating experiences and merchandising by life stage 32:22 The evolving role of pharmacists and in-store health services 39:11 Challenges facing pharmacy location sustainability 41:27 Tech industry disconnect and opportunities in retail 44:57 AI build vs. buy and organizational ownership 45:41 Data privacy, HIPAA, and AI regulation 47:06 Lightning round: personal preferences and insights